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Abstract 
Alcohol consumption during pregnancy can lead to physical irregularities and deficits in 
cognition collectively known as fetal alcohol spectrum disorders (FASD).  Impairments in 
cognition, particularly hippocampus-dependent memory, may be due to ethanol-induced 
neuroinflammation resulting from third trimester alcohol consumption, a period of development 
in which the brain undergoes rapid growth and synaptogenesis.  This study utilized a third 
trimester binge-drinking rodent model of FASD, in which rats were intubated and given ethanol 
(5g/kg/day; 5E) or sham intubated (SI) over postnatal days (PD)4-9.  The ability of two anti-
inflammatory drugs, ibuprofen and glycyrrhizin, to normalize neuroinflammation and cognition 
were investigated.  Animals in the ibuprofen group received subcutaneous injections 2h 
following ethanol treatment (100mg/kg on PD4, 50mg/kg/day following, IBU) or an equivalent 
volume of PBS (vehicle; VEH).  Glycyrrhizin animals received the drug (20mg/kg/day; GLY) or 
an equivalent volume of VEH via intraperitoneal injections 20-30min prior to ethanol 
administration.  On PD10 the rats were euthanized and hippocampi removed for quantification of 
inflammation-related gene expression.  In the IBU experiment, but not the GLY experiment, the 
5E-VEH rats showed significant increases in hippocampal IL-1β and TNF-α, but not CD11B or 
GFAP, expression compared to SI-VEH and 5E-IBU.  Next, we assessed in juvenile 5E rats 
whether ibuprofen or glycyrrhizin could rescue previously documented deficits in Trace Fear 
Conditioning (TFC), a challenging hippocampus-dependent associative memory task.  Results 
indicate IBU but not GLY rescued TFC test performance in 5E rats.  Taken together, postnatal 
ethanol upregulated pro-inflammatory cytokine expression on PD10 and impaired TFC over 
PD31-33. Ibuprofen, but not glycyrrhizin, ameliorated both effects, suggesting the potential 
benefits of anti-inflammatory drug treatment in improving cognition in FASD individuals. 
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Introduction 
Fetal Alcohol Spectrum Disorders (FASD), resulting from alcohol exposure during gestation, is 
estimated to affect 2-7 children in every 1000 births.  The disorder is characterized by deficits in 
behavior and cognition, as well as physical irregularities, such as facial dysmorphology (Hoyme 
et al., 2005). Impairments in behavior and cognition include difficulties in executive function, 
and learning and memory (Kodituwakku, 2009).  However, there is a lack of established 
diagnostic methods and measurements, leading to difficulties in making definitive diagnoses, 
particularly in the absence of overt dysmorphology (May et al., 2009).   
FASD is a term that covers a variety of distinct diagnoses resulting from alcohol consumption 
during pregnancy.  Among these are Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol 
Syndrome (PFAS), Alcohol Related Birth Defects (ARBD), and Alcohol Related 
Neurodevelopmental Disorder (ARND).  FAS is the most easily recognized of these diagnoses, 
and is characterized by growth deficiency, facial dysmorphology including small eyes and a 
smooth philtrum, and severe central nervous system abnormalities (Banakar et al., 2009).  This 
disorder is known to be the most preventable cause of intellectual disabilities in the world, and is 
estimated to cost $1.4 million per individual for lifetime care (American Academy of Pediatrics).  
The PFAS diagnosis is given to individuals who have most, but not all, of the growth 
deficiencies and facial abnormalities characteristic of FAS.  ARBD is identified by facial 
dysmorphology and a confirmation of prenatal alcohol exposure, but no abnormalities in growth 
or central nervous system features.  Lastly, ARND is diagnosed in cases of central nervous 
system dysfunction and confirmation of maternal alcohol consumption (Banakar et al., 2009); the 
lack of obvious physical abnormalities makes ARND difficult to diagnose.  The experiments 
below model ARND in rats. 
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Impairments in the central nervous system can result in difficulties in cognitive functioning in 
individuals with FASD.  Facial abnormalities do not need to be present for an FASD diagnosis – 
in fact, the majority of FASD individuals do not exhibit physical anomalies.  In contrast, 
evidence suggests that neurocognitive deficits present similarly in individuals diagnosed across 
the FASD spectrum (Nash et al., 2006).  Children with FASD have average IQs in the borderline 
to low average range, as well as deficits in various areas of cognitive function, including 
executive functions like planning, attentional set shifting, concept formation, and error 
correction.  Children with FASD had greater difficulty with executive control tasks requiring 
high levels of manipulation and regulation, and slowed information processing was seen in both 
children and toddlers.  As the neurocognitive demands of tasks in memory and language were 
increased, the performance of FASD children declined at a more rapid rate than that of control 
groups.  Particularly with tests of memory, children with FASD showed deficits when the tasks 
involved conscious effort, such as free recall and organization (Kodituwakku, 2009). 
The mechanism by which early life ethanol produces cognitive dysfunction is still unclear.  
Recent studies have focused on ethanol causing damage to brain structures by activating the 
neuroinflammatory system (Drew et al., 2015).  In the brain, ethanol may directly activate toll-
like receptor 4 (TLR4) on microglia, or indirectly activate it via the release of high-mobility 
group box 1 (HMGB1) protein, an endogenous TLR4 ligand (Zou and Crews, 2014).   To do so, 
ethanol inhibits histone deacetylases (HDACs), leading to increased production and acetylation 
of HMGB1, allowing movement of the protein into the cytoplasm and the extracellular 
environment.  Among the downstream effects of ethanol or HMGB1 binding to TLR4, nuclear 
factor kappa B (NFᴋB) activates cyclooxygenase (COX)-2, leading to the release of pro-
inflammatory cytokines such as interleukin (IL)-1β and tumor necrosis factor (TNF)-α (Alfonso-
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Loeches et al., 2010) (Figure 1).  Postnatal ethanol exposure can cause neuroinflammation in the 
hippocampus, among other regions (Drew et al., 2015; Tiwari and Chopra, 2011; Topper et al., 
2015), which may be particularly harmful during early development due to low levels of 
antioxidants in the brain (Brocardo et al., 2011).  Increased neuroinflammation and decreased 
antioxidant properties may interfere with normal processes of neural development, including 
synaptic pruning (Paolicelli et al., 2011), neurogenesis (Bland et al., 2010b), and synaptic 
plasticity (Bilbo and Schwarz, 2009).  This damage is thought to contribute to impairments in 
executive function, and learning and memory seen in FASD individuals and rodent models. 
 
 
Figure 1.  A schematic of the neuroinflammatory process by which ethanol induces an elevated inflammatory 
profile and mechanisms of the anti-inflammatory drugs, IBU and GLY. 
5 
 
Modulation of normal development by early life inflammation results in differences in the brain 
and behavior in adulthood.  Cytokines have been implicated in normal brain development, 
including neuronal and glial cell migration and differentiation, and synaptic pruning (Nawa and 
Takei, 2006).  For example, expression of cluster of differentiation protein 11B (CD11B) and 
resulting reactive oxygen species have been shown to be important for normal developmental 
neuronal death (Wakselman et al., 2008).  However, over-expression of cytokines such as IL-1β, 
IL-6, and TNF in early life, for example due to perinatal complications (Miller et al., 1990) or 
bacterial meningitis, have been correlated with neurological disorders (Mustafa et al., 1989).  
The early activation of inflammation was linked to later-life cognitive dysfunction, including 
deficits in learning and memory and attention disorders (Bauman et al., 1997).  Ethanol has been 
shown to have region-specific effects in the brain, rather than causing a global depression of all 
brain activity (White et al., 2000).  In particular, the hippocampus was found to be especially 
vulnerable to inflammatory stress compared to other brain regions.  Over-activation of the 
inflammatory response early in life caused by ethanol exposure is proposed to induce damage to 
the developing hippocampus and cause cognitive deficits later in life (Bilbo & Schwarz, 2009).   
Similar to children with FASD who struggle with Pavlovian associative memory (Jacobson et al., 
2008), rats exposed to ethanol demonstrate deficits in hippocampus-dependent memory, which 
can be tested using Trace Fear Conditioning (TFC).  TFC is a cognitively challenging Pavlovian 
task that depends on a distributed neural circuit, including the hippocampus and prefrontal cortex 
(Gilmartin et al,. 2013).  TFC is an important FASD modeling task as it can be used test many of 
the executive function deficits seen in FASD individuals, including attention, working memory, 
and long term memory (Kodituwakku, 2009).  In TFC, a conditioned stimulus (CS), a tone, is 
separated in time from an unconditioned stimulus (US), a footshock, by a 15s stimulus-free trace 
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interval (TI) (Figure 2B).  Although it is unclear the exact role of the hippocampus in TFC, it is 
thought to be important for the integration of multi-modal information – in this case, the 
temporally separated CS and US (Quinn et al., 2002).  Interestingly, the dorsal hippocampus is 
only required when the TI is longer than approximately 5s (Chowdhurty et al., 2005).  Prior work 
also demonstrated that FASD model rats were impaired in TFC memory tests when the TI was 
approximately 5s or longer (DuPont et al., 2014; Wagner and Hunt, 2006), suggesting impaired 
TFC CS-US associative memory is likely due to hippocampal dysfunction. 
 
 
Figure 2.  A schematic of trace fear conditioning.  Trace fear conditioning acquisition, context test, and in a novel 
context, CS-alone test (A). An example of a single conditioning session trial, showing 15s trace interval and total 
30s interstimulus interval (ISI) consisting of 15s CS and 15s TI (B).   
 
 
B 
A 
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Previous studies have found that rats exposed to ethanol during the third trimester equivalent of 
human pregnancy exhibited significant reductions in CS-evoked conditioned fear (DuPont et al., 
2014, Hunt et al., 2009).  This reduced freezing to the CS is proposed to reflect impairments in 
synaptic plasticity and memory consolidation, not encoding (Runyan et al., 2004).  Memory 
encoding and consolidation are thought to be facilitated in part by N-methyl-D-aspartate receptor 
(NMDAR), a glutamatergic Ca2+ channel, which can be found in the hippocampus (Quinn et al., 
2005).  Postnatal ethanol can cause long lasting changes to NMDAR subunits and NMDAR-
dependent signaling, such as decreased ERK1/2 phosphorylation, both of which underlie long-
term potentiation (LTP) maintenance and CS-US associative memory consolidation (Goodfellow 
et al., 2016, DuPont et al., 2014).  In addition, IL-1β release also contributes to LTP maintenance 
and hippocampus-dependent memory consolidation in a dose-dependent, bell-curve-like manner 
in which either too little or too much impairs consolidation (Williamson et al., 2011, Yirmiya et 
al., 2002, Goshen et al., 2007).  Neonatal elevations in inflammatory cytokines in response to 
postnatal ethanol may lead, in juvenile 5E rats submitted to TFC, to experience-dependent 
discrete changes in IL-1β release and synaptic plasticity, contributing to a weaker (less 
consolidated) TFC memory and diminished CS-evoked freezing behavior.   
In the experiments below, rats were intubated with ethanol (5g/kg/day; 5E), or sham intubated 
(SI) over postnatal days (PD) 4-9.  This time period is comparable to brain development during 
the third trimester of pregnancy in humans (Bayer et al., 1993), when the brain is extremely 
susceptible to neurotoxic damage as it undergoes rapid growth and synaptogenesis (Gil-Mohapel 
et al., 2010).  Exposing rats to ethanol during this period has been shown to result in neural 
degeneration in the hippocampus (Ikonomidou et al., 2000) and hippocampus-dependent TFC 
memory deficits (DuPont et al., 2014; Hunt et al., 2009).   
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This study investigated the effectiveness of two anti-inflammatory drugs, ibuprofen (IBU) and 
glycyrrhizin (GLY), on normalizing acute inflammatory expression on PD10 and ameliorating 
TFC memory deficits in juvenile (PD31-33) 5E rats.  IBU is a non-steroidal anti-inflammatory 
drug that works through the inhibition of COX-2, which was injected 2h following PD4-9 
ethanol administration.  GLY is an anti-inflammatory drug that works by preventing the binding 
of HMGB1 and TLR4 (Mollica et al., 2007), which was injected 20-30m prior to ethanol 
treatment on PD4-9.  IBU was administered following ethanol administration, as it blocks the 
effects of the metabolites of ethanol.  GLY, on the other hand, inhibits the actions of ethanol and 
not its metabolites, therefore GLY treatment occurred prior to ethanol administration.  On PD10, 
mRNA quantification of IL-1β, TNF-α, microglial marker (CD11B), and astrocyte marker (glial 
fibrillary acidic protein; GFAP) were used to quantify neuroimmune activation.  Separate groups 
of IBU and GLY treated juvenile 5E rats underwent TFC for investigation of hippocampal-
dependent memory consolidation.  Both anti-inflammatory treatments were hypothesized to 
normalize ethanol-induced neuroinflammation in the hippocampus, and alleviate associative 
memory deficits in 5E juvenile rats.   
 
Materials & Methods 
Subjects & Neonatal Treatment 
All procedures followed the guidelines of The Ohio State University Institutional Animal Care 
and Use Committee (IACUC).  All appropriate measures were taken to minimize discomfort and 
pain in the animals.  Long-Evans rats purchased from Envigo Laboratories (Indianapolis, IN) 
were housed and bred with ad libitum food and water on a 12h light/dark cycle in The Ohio State 
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University psychology vivarium, an Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC)-accredited facility.  One male and one female were pair-housed for one 
week, then females were checked daily beginning 3 weeks later for pups.  After birth, pups were 
kept with their mother until weaning at PD21, when they were housed with 1-2 same-sex 
littermates.  On PD3, the litters were culled to a maximum 12 animals per litter.  The pups were 
subcutaneously injected a 30 gauge needle with non-toxic black ink for identification and 
separated into treatment groups.   
On PD4-9, male and female rats received binged-like doses of ethanol (5g/kg/day; 5E) in milk 
solution (11.33% vol/vol) via intragastric intubation, in which polyethylene tubing was 
lubricated with corn oil and lowered into the stomach through the esophagus.  Animals in the 
ibuprofen (100mg/kg on PD4, 50mg/kg PD5-9; IBU) group received the drug or an equivalent 
volume of phosphate buffered saline vehicle (VEH) via subcutaneous (SC) injections 2 h after 
ethanol administration (Carty et al., 2011).  Rats in the glycyrrhizin (20mg/kg/day; GLY) 
received intraperitoneal (IP) injections of the drug of an equivalent volume of saline (VEH) with 
30 gauge needles 20-30min prior to ethanol treatment (Yamamura et al., 1995; Wang et al., 
2015).  The rats received milk only intubations 2h later, with a third milk alone dose only on 
PD4.  The milk alone intubations supplemented the caloric intake of 5E animals that may nurse 
less due to inebriation.  Sham intubated (SI) rats received intragasteric intubations but no 
solution.  Prior to the first milk alone dose on PD4, 5E and SI pups were tail clipped and 
approximately 40μL of blood collected for blood alcohol concentration (BAC) analysis.  
Following tail clipping, blood clotting was promoted by dipping the rats’ tails in Kwik-Stop® 
styptic powder with benzocaine (ABC Laboratories, Dayton, OH).  Blood collected from SI rats 
were discarded.  Blood from 5E rats collected in capillary tubes were transferred into 
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micropipette tubes and centrifuged for 10min to separate plasma.  The plasma was separately 
stored at -80°C until analysis via an Analox GL5 Analyzer (Analox Instruments, Lunenberg, 
MA).  The Analox GL5 Analyzer measured the rate of oxygen consumption via the oxidation of 
ethanol in the plasma samples, which was compared to a known ethanol standard used for 
instrument calibration.  Rats were weighed each day of intubations, then again on PD10, PD15, 
PD21 and PD30 (in groups undergoing TFC) to track development. 
 
 
 
Figure 3.  Timeline of Treatment and Behavioral Testing 
 
Polymerase Chain Reaction 
Rats were euthanized with isoflurane and decapitated on PD10 and hippocampi collected.  A 
Total RNA Tissue Kit (IBI, Peosta, IA) and DNase1 (Qiagen, Valencia, CA) was used to isolate 
RNA from the dorsal hippocampus.  First Strand cDNA Kit from Origene (Rockville, MD) was 
used to prepare cDNA, which was then diluted (1:5).  A mastermix of Bullseye EvaGreen 
Supermix (MidSci, St. Louis, MO), primers (PrimeTime® GAPDH and IL-1β, or custom GFAP, 
TNF-α, and CD11B), and water were added to the cDNA.  Assays were run in triplicates 
(CD11B, GFAP) or quadruplicates (IL-1β and TNF-α) using GAPDH as a normalizing 
comparison (citation).  The assays were run with a CFX96, C1000 Thermal Cycler (Bio-Rad, 
Richmond, CA) and quantified via the comparative cycle threshold (2-ΔΔCt) method.  Primer 
sequences used (5’-3’) were as follows: GAPDH (forward: AACCCATCACCATCTTCCAG, 
PD4 PD0 PD9 PD10 PD31 PD33 
Birth Intubations & Injections Sac TFC 
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reverse: CCAGTAGACTCCACGACATAC), CD11B (forward: 
CTGGGAGATGTGAATGGAG, reverse: ACTGATGCTGGCTACTGATG) (Bland et al., 
2010a), GFAP (forward: AGATCCGAGAAACCAGCCTG, reverse: 
CCTTAATGACCTCGCCATCC) (Frank et al., 2012), IL-1β (forward: 
GTGCTGTCTGACCCATGT, reverse: TTGTCGTTGCTTGTCTCTCC), and TNF-α (forward: 
GACCCTCACACTCAGATCATCTTCT, reverse: TGCTACGACGTGGGCTACG) 
(Fernandez-Lopez et al., 2012).   
Trace Fear Conditioning 
Rats were weaned on PD21 and housed with 2-3 littermates of the same sex.  Body weight was 
recorded on PD10, PD15, PD21, and PD30.  Conditioning and tests occurred on PD31-33 in 5E 
and SI rats placed inside standard operant boxes (Coulbourn Instruments, Allentown, PA).  
These boxes were made up of two stainless steel and two Plexiglas® walls with a floor of .5cm 
stainless steel bars 1.5cm apart.  Footshocks (US) were delivered via a shock generator 
(Lafayette Instruments, Lafayette, IN) connected to the grid floor.  An infrared camera (Circuit 
Specialists, Inc., Mesa, AZ) at the top of the box recorded freezing behavior (a species-specific 
fear response), which was transmitted to FreezeScan (CleverSys, Inc., Reston, VA) to quantify 
freezing behavior according to experimenter-defined time bins.  
Rats were separated into clean cages in the vivarium and carried to a well-lit testing room.  The 
operant boxes, illuminated by a 15W bulb, were scented with a vinegar/water (1:5) solution 
before the rats were placed inside.  Following a baseline of 180 ± 30s, rats were presented with a 
15s, 2.8kHz, 80dB tone CS, then 15s later (trace interval; TI) a 1s, 0.8mA footshock (US).  The 
inter-stimulus interval (ISI), therefore, was 30s from CS onset to US onset.  The rats received a 
total of 10 CS-US presentations, separated by an inter-trial interval of 180 ± 30s.  Rats 
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underwent context and CS-alone testing at 24 and 48 h later, respectively (Figure 2), with no foot 
shocks in either test.  The context test was run under the same conditions as the acquisition, and 
freezing was measured for 10 minutes following a 2min baseline.  CS-alone tone testing was 
conducted in a novel context, to which the rats were wheeled into on metal carts in darkened 
cages.  The chambers were unilluminated, scented with Windex®, and gray plexiglass covered 
the grid bars.  In addition, white noise was produced by a fan, and a magnet and pink geometric 
Figure were placed on separate walls.  Freezing behavior was measured across ISI for the 
acquisition and tone test sessions. 
Statistical Analyses 
Data was analyzed via single-factor analyses of variance (ANOVA) and, when appropriate, 
Fisher’s LSD post-hoc tests (significance implies p<0.05).  PCR was performed in 57 rats total, 
27 the IBU experiment: SI-VEH (n=9), 5E-VEH (n=8), and 5E-IBU (n=10).  The remaining 30 
were in the GLY experiment: SI-VEH (n=10), 5E-VEH (n=10), and 5E-GLY (n=10).  A total of 
57 rats underwent TFC, with 27 in the IBU experiment, SI-VEH (n=9), 5E-VEH (n=8), and 5E-
IBU (n=10).  Thirty rats were in the GLY experiment, SI-VEH (n=10), 5E-VEH (n=10), and 5E-
GLY (n=10).  
 
Results 
Blood Alcohol Concentration 
The mean (±SE) BAC for the IBU experiment was 348.0 ± 7.21mg/dL and 360.6 ± 6.56mg/dL 
for 5E-VEH and 5E-IBU treatment groups, respectively.  Mean (±SE) BAC in the GLY 
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experiment was 360.8 ± 6.22mg/dL for 5E-VEH rats and 358.4 ± 5.02mg/dL for 5E-GLY rats.  
Single-factor (Drug) ANOVA found no significant differences in BAC levels between groups.   
 
Body Weights 
Body weights were analyzed on the first day of treatment (PD4) and one day after the end of 
treatment (PD10) via single-factor (Treatment) ANOVAs for rats undergoing PCR.  In the IBU 
experiment, significant differences were found at PD10 F(2,27) = 3.02, p<0.05, but not at PD4 
(p=0.37) (Table 1).  Post-hoc tests showed that 5E-IBU rats weighed significantly less than SI-
VEH and 5E-VEH rats.  Significant differences in body weight were also found in the GLY 
experiment at PD10, F(2,24) = 9.915, p<0.05, but not at PD4 (p=0.65) (Table 2).  Post-hoc tests 
indicated that SI-VEH rats weighed significantly more than 5E-VEH and 5E-GLY rats.  Rats 
undergoing TFC were weighed again at PD15, PD21, and PD30 to track development.  As 
shown in Table 1, no significant treatment group differences were found at these times (p=0.44, 
p=0.68, p=0.55 at PD15, PD21, and PD30, respectively).  Similarly, Table 2 shows no 
significant differences in body weight between treatment groups at these times in development 
(p=0.26, p=0.37, and p=0.64 for PD15, PD21, and PD30, respectively).    
 
IBU PD4 PD10* PD15 PD21 PD30 
SI-VEH (n=9) 9.87 ± 0.69 20.68 ± 1.35 33.91 ± 1.67 52.41 ± 2.76 95.87 ± 5.89 
5E-VEH (n=8) 10.88 ± 0.35 20.19 ± 1.02 35.00 ± 0.78 54.08 ± 1.15 100.32 ± 2.15 
5E-IBU (n=10) 10.69 ± 0.49 19.3 ± 1.07 32.16 ± 1.70 50.83 ± 2.84 93.20 ± 4.16 
 
Table 1.  Body Weight (g) across development of rats undergoing TFC in the IBU experiment.  At PD10 5E-
IBU rats weighed significantly less than SI-VEH and 5E-VEH rats.  Significance is denoted by *. 
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GLY  PD4 PD10* PD15 PD21 PD30 
SI-VEH (n=10) 10.22 ± 0.51 20.89 ± 0.94 30.96 ± 1.27 47.84 ± 2.18 85.98 ± 6.11 
5E-VEH (n=10) 9.49 ± 0.46 18.08 ± 0.86 28.49 ± 1.02 45.02 ± 1.32 82.69 ± 2.97 
5E-GLY (n=10) 11.1 ± 0.30 19.71 ± 0.72 30.08 ± 0.73 48.71 ± 1.92 88.67 ± 3.12 
 
Table 2.  Body Weight (g) across development of rats undergoing TFC in GLY experiment.  At PD10 SI-VEH 
rats weighted significantly greater than 5E-VEH and 5E-GLY rats.  Significance is denoted by *. 
 
 
Polymerase Chain Reaction 
Gene expression data for pro-inflammatory cytokines were normalized to SI-VEH animals for 
both IBU and GLY experiments.  For each gene, expression was normalized to the expression of 
the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which did not 
vary between groups.  Figure 4A-B shows that neonatal ethanol treatment in the IBU experiment 
had no significant effect on the expression of CD11B (p=0.32) or GFAP (p=0.61).  In the IBU 
experiment, postnatal ethanol significantly altered the expression of IL-1β, F(2,24) = 4.32, 
p<0.05, and TNF-α, F(2,24) = 6.74, p<0.01, as seen in Figures 4C-D.  Gene expression of both 
inflammatory cytokines were significantly elevated in the 5E-VEH rats compared to SI-VEH and 
5E-IBU rats.  In contrast, rats in the 5E-VEH treatment groups did not show significant 
elevations in the expression of CD11B (p=0.08), GFAP (p=0.49), IL-1β (p=0.34), or TNF-α 
(p=0.94), compared to 5E-GLY or SI-VEH animals (Figure 5A-D).   
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Figure 4.  PCR: Gene expression of pro-inflammatory cytokines in IBU treatment groups at PD10.  Gene 
expression was normalized to GAPDH as a percentage of group SI-VEH expression.  CD11B (A) and GFAP (B) 
were not significantly affected by neonatal ethanol treatment.  Ethanol treatment significantly elevated expression of 
IL-1β (C) and TNFα (D), as seen in the 5E-VEH treatment group compared to all other groups.  Significance is 
denoted by *. 
 
 
* * 
A B 
C 
D 
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Figure 5.  PCR: Gene expression of pro-inflammatory cytokines in GLY treatment groups at PD10.  Gene 
expression was normalized to GAPDH as a percentage of group SI-VEH expression.  Neonatal ethanol treatment 
had no significant effect on the expression of CD11B (A), GFAP (B), IL-1β (C), or TNFα (D). 
 
 
Trace Fear Conditioning 
Consistent with results seen in DuPont et al. (2014) in adult rats and in Hunt et al. (2009) in 
adolescent rats, no group differences were seen in the mean freezing across the ISI during TFC 
acquisition in either the IBU or GLY experiments, p=0.71 (data not shown) and p=0.94 (data not 
shown), respectively.    There were also no differences in mean freezing during the 10min 
context test in either experiment, p=0.89 (Figure 6A) and p=0.87 (Figure 7A).  In the novel 
context, there were no differences in mean freezing between treatment groups during the 2min 
A B 
C D 
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baseline in either the IBU or GLY experiments  (p=0.69, Figure 6B; p=0.99, Figure 7B), 
signifying a successful context switch.  Significant differences were found in mean freezing 
during the ISI by treatment group in the IBU experiment, F(2,24) = 5.61, p<.01 (Figure 6B), but 
not in the GLY experiment, p=0.99 (Figure 7B).  Post-hoc test indicated that mean freezing was 
significantly less in 5E-VEH rats compared to SI-VEH and 5E-IBU rats (Figure 6B).   
 
 
Figure 6.  TFC Freezing behavior in IBU treatment groups at adolescence (PD31-33).  Mean (±SE) freezing did 
not differ between treatment groups during the context test (A) or the 2 min baseline in a novel context (B).  
Freezing during the ISI (CS+TI) was significantly enhanced in 5E-VEH rats compared to SI-VEH and 5E-IBU rats 
(B).  Significance is denoted by *.      
 
  
Figure 7.  TFC freezing behavior in GLY treatment groups at adolescence (PD31-33).  Mean (±SE) freezing 
did not differ between treatment groups during acquisition (not shown), the context test (A), the 2 min baseline in a 
novel context, or during the ISI (CS+TI) (B). 
* 
A 
A 
B 
B 
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Discussion 
This thesis investigated the ability of two anti-inflammatory drugs, IBU and GLY, to attenuate 
ethanol-induced neuroinflammation and later-life executive function and memory deficits in later 
life.  Results from the IBU experiment indicated a significant upregulation of pro-inflammatory 
cytokines IL-1β and TNF-α, but not of CD11B or GFAP, at PD10 in 5E-VEH rats as a result of 
early-life ethanol exposure.  Elevated cytokine gene expression was not found in 5E-VEH rats in 
the GLY study, and no significant differences between treatment groups were seen.  TFC test 
performance results indicated that PD4-9 ethanol exposure significantly decreased CS-evoked 
freezing behavior in 5E-VEH rats in the IBU experiment.  As seen with elevations in 
neuroinflammation, IBU treatment increased freezing during the ISI in 5E-IBU rats relative to 
5E-VEH rats.  Significant treatment group differences in neuroinflammatory markers on PD10 or 
later-life TFC test performance were not found in the GLY experiment. 
Neonatal Neuroinflammation 
Ethanol is predicted to initiate neuroinflammation in one of two ways.  It may directly activate 
TLR4 on microglia (Pascual et al., 2011), leading to release of pro-inflammatory cytokines such 
as IL-1β and TNF-α (Drew et al., 2015, Topper et al., 2015).  Alternatively, ethanol may 
indirectly activate TLR4 through HMGB1 release (Zou and Crews, 2014).  Based on these 
possible mechanisms of inflammation, our study used two anti-inflammatory drugs: IBU and 
GLY (Figure 1).  IBU is a non-steroidal anti-inflammatory drug that works through the inhibition 
of COX-2.  GLY inhibits the binding of HMGB1 and TLR4 to block the downstream 
enhancement in inflammation (Zou and Crews, 2014).  CD11B is a protein found on the surface 
of microglia and can be used as a preliminary indicator of microglial activation (Crain et al., 
2013).  Astrocytes may also contribute to neuroinflammatory response, as IL-1β has been shown 
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to downregulate glutamate transporter 1 (GLT1) on astrocytes to increase synaptic glutamate 
concentrations (Liu et al., 2013).  The implications of these molecules in ethanol-induced 
inflammation were investigated in this thesis by looking at PD10 gene expression of CD11B, 
GFAP, and pro-inflammatory cytokines IL-1β, and TNF-α. 
Past studies investigating FASD have used CD11B and GFAP expression as indicators of 
microglia and astrocytes.  Alfonso-Loeches et al. (2010) found significant upregulation in 
CD11B and GFAP, as well as IL-1β and TNF-α with chronic ethanol exposure.  In a study of 
ethanol exposure over PD4-9, CD11B was investigated as a pro-inflammatory cytokine and 
found to be elevated in the hippocampi of both ethanol-exposed and SI rats (Boschen et al., 
2016).  Topper et al. found increased expression of GFAP as a marker for astrocytes at PD10 
(2015).  Also, Topper et al. (2015) and Drew et al. (2015) both reported an increased expression 
of pro-inflammatory cytokines IL-1β and TNF-α at PD10, during the ethanol withdrawal period 
(Drew et al., 2015; Topper et al., 2015).  Consistent with these finding, results from the IBU 
experiment showed increased hippocampal gene expression of IL-1β and TNF-α, but not of 
CD11B (microglia) or GFAP (astrocytes) at PD10 in 5E-VEH rats (Figure 4A-D).  Previous 
studies have also shown a reduction of hippocampal IL-1β and TNF-α expression when treated 
with an immunosuppressant, pioglitazone (Drew et al., 2015).  Similarly, this study demonstrated 
IBU was able to attenuate the elevated inflammatory cytokine response in 5E-IBU rats at PD10.   
In contrast, the expected elevations in pro-inflammatory gene expression were not found in 5E-
VEH rats of the GLY experiment.  Previous studies have found that GLY treatment reduces 
ethanol-induced gene expression of IL-1β and TNF-α (Zou & Crews, 2014).  However, results 
from this study indicated that rats in the GLY experiment did not show significant changes in the 
expression of CD11B, GFAP, IL-1β, or TNF-α between treatment groups (Figure 5A-D).  The 
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lack of significant elevations in IL-1β and TNF-α expression in 5E-VEH contradicted previous 
studies that found neonatal ethanol exposure increases hippocampal inflammatory cytokine 
expression at PD10 (Topper et al., 2015).  Additionally, the lack of significant differences 
between 5E-VEH and 5E-GLY rats contradicted studies by Zou & Crews (2014), which found 
that GLY treatment attenuated ethanol-induced elevation of IL-1β and TNF-α expression in the 
hippocampal-entorhinal cortex.  A similar study showed that GLY treatment mitigated elevated 
hippocampal IL-1β and TNF-α expression to normalize memory deficits (Wang et al., 2015).  
However, the protocol used by Zou & Crews utilized GLY exposure to brain slices, rather than 
exposure via injections in live rats (2014).  Additionally, the lack of significant differences in 
neuroinflammation between treatment groups may have been due to the stress caused by IP 
injections.  Studies such as Ryabinin et al. (1999) have utilized IP injections to induce stress and 
stress-related immunoreactivity in the brain.  Additional stress caused by the injections may have 
led to increased pro-inflammatory cytokine expression, so that no significant differences between 
treatment groups were found.   
In addition, GLY has been found to inhibit TLR4 internalization, so that once the receptor has 
been stimulated it cannot move intracellularly into the microglia (Schröfelbauer et al.,2009).    
The GLY injections 20-30 min prior to ethanol administration may have assisted in the induction 
of the inflammatory cascade by maintaining TLR4 on the extracellular surface of microglia and 
maintaining microglial activation.  If GLY is broken down quickly, it is possible that the 
neuroprotective effects of the drug are ineffective compared to the lasting membrane-
stabilization effects.  However, GLY has a half-life of 2.5-2.9h, and reaches maximum plasma 
levels within 30m of injections (Yamamura, et al., 1995), so it is unlikely that the membrane 
sustaining effect would last longer than its inhibition of HMGB1 and TLR4 binding.  In addition, 
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data from this study contradicted this theory, as there were no significant elevations in microglial 
activation or pro-inflammatory cytokines in 5E-GLY rats (Figure 5B).   
Lastly, the expected increase in inflammation in 5E-VEH rats was absent in the GLY 
experiment, suggesting the effect may be due too little information in 5E-VEH rats rather than 
the inability of GLY to mitigate neuroinflammation. The reason behind the absence of 
replication of increased neuroinflammation at PD10 in 5E-VEH rats as found by other studies 
such as Drew et al. (2015) and Topper et al. (2015), as well as the IBU experiment is unknown.  
It is possible the lack of ethanol-induced inflammation could have been due to a sex effect, as 
males and females have different neuroinflammatory profiles throughout development (Schwarz 
et al., 2012).  As such, it is possible there would be sex-specific results of immune activation.  
Many studies, such as Wang et al. (2015), use only male rats, therefore, the ethanol-induced 
inflammatory profile of groups containing both males and females may be different.   
Trace Fear Conditioning 
Among treatment groups in both the IBU and GLY experiments, no significant differences were 
found during training, suggesting CS-US associative memory acquisition is intact following 
postnatal ethanol exposure. No treatment group differences were seen for context-elicited fear 
(Figures 6A and 7A).  In the IBU experiment, the 5E-VEH rats did show diminished CS-evoked 
freezing behavior compared to SI-VEH and 5E-IBU rats (Figure 6B).  There were no differences, 
however, between treatment groups in CS-evoked freezing in the GLY experiment (Figure 7B). 
Jacobson et al. previously showed that children with FASD are impaired in eyeblink 
conditioning, a Pavlovian task that asked the children to associate a CS with an aversive US 
(2008).  Similarly, in this study, cognition in rats was tested using TFC, a Pavlovian paradigm 
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that relies on a distributed forebrain circuit (Raybuck and Lattal, 2014) and engages the dorsal 
hippocampus when the TI is longer than approximately 5s (Guimarãis et al., 2011).  This is the 
same length of TI at which significant deficits have been seen previously reported in juvenile and 
adult rats exposed to PD4-9 ethanol (DuPont et al., 2014, Hunt et al., 2009), indicating dorsal 
hippocampal dysfunction is primarily responsible for TFC deficits in 5E rats.  Hippocampus 
dysfunction in TFC is thought to be related to deficits in LTP maintenance and memory 
consolidation (DuPont et al., 2014; Goodfellow et al., 2016).  Specifically, evidence suggests 
that ethanol disrupts hippocampus-related cognition by disrupting the subunit composition and 
function of NMDA receptors, which are abundant in the hippocampus and involved in LTP 
induction and maintenance.  The NMDAR consists of either NR2A or NR2B subunits, along 
with consistent NR1 subunits.  The NR2 subunits play a role in determining the channel kinetics 
of NMDARs, leading to downstream signaling transduction cascades and LTP.  The expression 
of NR2 subunits differ across development, with NR2B subunits normally being expressed early 
in development (Monyer et al., 1994).   The NR2B subunits have a greater affinity for glutamate, 
as well as lower open channel probability and slower kinetics, and play a critical role in TFC 
(Gao et al., 2010).  Reduced NR2B expression compared to NR2A is proposed to impede LTP 
and learning and memory.  Goodfellow et al. (2016) found that postnatal ethanol exposure shifts 
the balance of NR2 subunits so that there is upregulation of NR2A and/or downregulation of 
NR2B, contributing to impaired synaptic plasticity and TFC memory deficits.   
Abnormal levels of IL-1β during or following TFC could also contribute to disruptions in LTP 
maintenance and memory consolidation (Yirmiya, et al., 2002, Williamson et al., 2011).  Early 
immune activation has been associated with increases in basal and experience-dependent 
inflammatory cytokine expression, specifically IL-1β (Wang et al., 2015).  In addition to basal 
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increases in inflammation due to early life ethanol exposure, neuroinflammatory profile may be 
elevated in response to the experience of TFC.  IL-1β also plays a role in LTP maintenance 
(Lynch, 2015; Williamson et al., 2011) and hippocampus-dependent context memory 
consolidation (Goshen et al., 2007).  Elevated basal levels of IL-1β from early-life ethanol 
exposure, and/or increased experience-dependent levels following TFC could contribute to 
deficits in LTP maintenance and memory consolidation seen in 5E-VEH rats in the IBU 
experiment, similar to the effects in juvenile and adult rats from previous studies (DuPonet et al., 
2014, Hung et al., 2009). 
Just as inflammation-related gene expression did not vary between groups in the GLY 
experiment, TFC results showed no significant differences in CS-evoked freezing (Figure 7A-B).  
As seen in other studies, freezing during the acquisition and to the context did not differ between 
treatment groups (Figure 4A-B) (Hunt et al., 2009).  However, the expected significant 
impairments tone-elicited conditioned fear in 5E-VEH rats compared to SI-VEH and 5E-GLY 
rats were not found (Figure 7B).  As discussed above, the lack of differences in CS-evoked 
freezing between treatment groups may be due to increased stress from ethanol or IP injections, 
as early life stress can affect later life cognition by causing changes in the developing 
hippocampus (Lupien et al., 2009).  In addition, proposed increased activation of microglia by 
GLY inhibition of the internalization of TLR4 (Schröfelbauer et al., 2009) may increase 
inflammation and damage the hippocampus.  However, gene expression data from GLY 
treatment animals at PD10 contradicted this, as there were no significant differences in pro-
inflammatory gene expression between treatment groups (Figure 5A-D). 
This current study contributed to prior research findings that postnatal ethanol results in 
cognitive deficits through, we propose, increased neuroinflammation in early life.  In the IBU 
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experiment, the 5E-VEH rats showed significant elevation in pro-inflammatory cytokines, which 
was significantly mitigated in the 5E-IBU rats.  However, the elevations of immune-related gene 
expression were not replicated in the GLY experiment as no significant differences in pro-
inflammatory cytokines were seen between treatment groups, possibly due to confounds in the 
research design.  In addition, 5E-VEH rats in the IBU experiment had impaired TFC memory 
deficits, an effect that was not seen in 5E-VEH rats of the GLY experiment.  The disruption in 
normal inflammatory profile and differences in synaptic plasticity are suggested to contribute to 
the deficits in memory consolidation.  Hippocampus-dependent TFC test performance was 
significantly enhanced in 5E-IBU but not 5E-GLY rats. The lack of significant effects in the 
GLY experiment may be due to the stress response to the IP injections and/or the absence of a 
significant deficit in the 5E-VEH rats.  The disruption in normal inflammatory profile and 
differences in synaptic plasticity are suggested to contribute to the deficits in memory 
consolidation.  Although IBU is contraindicated for use during pregnancy, results from the IBU 
experiment suggest that anti-inflammatory drugs could be an effective treatment for improving 
cognition in FASD individuals.  Although GLY did not have the same effect, other anti-
inflammatory drugs may still work to normalize inflammatory profile and cognitive function.  
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